Quest LaboratoriesNSE:QUESTLAB -1.56%44 Net Margin % is 8.86% as of Mar. 2026, which is 13% below its 10-year median of 10.21. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review. Among 956 Drug Manufacturers companies, Quest Laboratories ranks better than 60.25% on this metric.
The historical rank and industry rank for Quest Laboratories's Net Margin % or its related term are showing as below:
NSE:QUESTLAB'
s Net Margin % Range Over the Past 10 Years
Min: 2.16 Med: 10.21 Max: 13.43
Current: 8.86
NSE:QUESTLAB's Net Margin % is ranked better than 60.25% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs NSE:QUESTLAB: 8.86
Quest Laboratories (NSE:QUESTLAB) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Quest Laboratories Net Margin % Related Terms
Quest Laboratories Net Margin % Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Net Margin % Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Net Margin % distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a Net Margin % of 8.86% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Quest Laboratories and its competitors. This is 13% below median its historical median of 10.21. Over the past decade, Quest Laboratories' Net Margin % has ranged from 2.16 to 13.43. According to the industry distribution chart, Quest Laboratories ranks #380 out of 956 companies in the Drug Manufacturers industry, placing it in the top 39.7%.
Is Quest Laboratories' Net Margin % too high?
Quest Laboratories' current Net Margin % of 8.86% is 13% below median its 10-year median of 10.21. Over the past 10 years, this metric has ranged from a low of 2.16 to a high of 13.43. The Drug Manufacturers industry median Net Margin % is 5.56. Quest Laboratories' value of 8.86% is 59.4% above this industry median. Based on the distribution chart, Quest Laboratories ranks #380 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Net Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #380 out of 956 companies for Net Margin %. This puts Quest Laboratories in the upper half of its industry. The industry median Net Margin % is 5.56. Quest Laboratories' value of 8.86% is 59.4% above this benchmark. Historically, Quest Laboratories' own Net Margin % has ranged from 2.16 to 13.43 over the past decade. While the company's 10-year median is 10.21 vs. the industry median of 5.56, Quest Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current Net Margin % of 8.86% is 59.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Net Margin % is 8.86%, which is 13% below median its own 10-year median of 10.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Net Margin % of 8.86%. The current Net Margin % is 8.86%, which is 13% below median its 10-year median of 10.21 and 59.4% above the Drug Manufacturers industry median of 5.56. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Net Margin % is 8.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 